20 December 2021 This is an important announcement for our community engaged in fighting liver cancer and viral hepatitis. Given the current and evolving constraints and uncertainty triggered by COVID-19, the EASL Governing Board has decided that two events scheduled…
20 December 2021 On 22 November 2021, EASL held its annual Patient Forum on the topic: health literacy to empower patients and address inequities. We collaborated with five members of our Patient Synergies network to bring together the expertise of…
A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and metabolic-associated fatty liver disease (MAFLD), report scientists in the Journal of Hepatology. Amsterdam, December 6, 2021 – Metabolic-associated fatty liver disease (MAFLD) is a growing…
The EASL–Lancet Liver Commission calls for a paradigm shift in the liver disease response in Europe: prevention and early detection, not end-stage treatment of complications. Liver disease is now the second leading cause of years of working life lost in…
9 November 2021 With October being a month dedicated to promoting liver cancer awareness, EASL participated in numerous relevant activities. EASL leadership played a key role notably in two high-level advocacy events, coming to the heart of advocacy. The European…
5 November 2021 EASL, the European Society for Organ Transplantation (ESOT) with the European Liver and Intestine Transplantation Association (ELITA), and the International Liver Transplantation Society (ILTS), are calling transplant centres across the globe to share their experiences of offering…
Are you passionate about social media and scientific communication? Do you have a flair for starting online conversations? Does the idea of discussing your field of research with the world wide web delight you? If the mantra "like, share, comment"…
2 November 2021 EASL, the European Society for Organ Transplantation (ESOT) with the European Liver and Intestine Transplantation Association (ELITA), and the International Liver Transplantation Society (ILTS), are proud to announce the publication of findings of a jointly run survey…
22 October 2021 Since 2020 EASL Studio has been a part of the International Liver Congress (ILC), bringing you the most up-to-date research live from the congress. But EASL Studio is evolving. EASL Studio is now a new platform through which we will be exploring hepatology every week, from every angle. Through live debates,…
EASL’s engagement with nurses and Allied Health Professionals (AHPs) has been thriving through 2021. Their next contribution for the global liver community is a webinar by the EASL Nurses and AHPs Task Force in which they will be sharing their expertise on managing NAFLD in patients. …